Login / Signup

Identification of an immune signature to predict poor clinical outcome in cervical cancer.

Wenjing YanHua JinXing ZhangSigui LongQianqian XiaDan MengBo DingDake LiJingru MaJian CaoShizhi Wang
Published in: Epigenomics (2021)
Aim: To explore tumor immune microenvironment and identify immune prognostic-related circRNAs in cervical cancer. Materials & methods: RNA-seq in combination with bioinformatics were performed to establish a prognostic risk model and a circRNAs-miRNAs-CXCL8 network. Results: High-risk group correlated with poor survival outcome, and had lower PD-1 immunogenicity. Additionally, CXCL8 could distinguish normal tissue, low- and high-risk tumor tissues, the expression of which showed an increasing trend among the three groups. RNA-seq and bioinformatics indicated that circRNAs like hsa_circ_0025721 might upregulate CXCL8 through sponging miRNAs including hsa-miR-4428. Conclusion: We constructed an immune risk model related with CD8 T cells to predict the cervical cancer patients' prognosis and explored the abnormal expression mechanism of CXCL8 through the ceRNA mechanism.
Keyphrases
  • rna seq
  • single cell
  • poor prognosis
  • long non coding rna
  • cell proliferation
  • stem cells
  • binding protein
  • long noncoding rna
  • free survival